Evidence map›Paper›PMID 39105621›Full record

ArticleImmunotherapy2024

A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study.

Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, Giuseppe Fornarini, Marco Maruzzo, Paolo Andrea Zucali, Fabio Catalano, Ludovica Antonj, Marianna Tudini, Lucia Fratino and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shobana AnpalakhanSouthampton General Hospital, University Hospital Southampton NHS Trust, UK.
Giuseppe Luigi BannaSouthampton General Hospital, University Hospital Southampton NHS Trust, UK.
Sara Elena RebuzziMedical Oncology Unit, Ospedale San Paolo, Savona, Italy.
Giuseppe FornariniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Marco MaruzzoMedical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
Paolo Andrea ZucaliDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Fabio CatalanoMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Ludovica AntonjMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Marianna TudiniMedical Oncology, St Salvatore Hospital, L'Aquila, Italy.
Lucia FratinoDepartment of Medical Oncology, Centro di Riferimento, Oncologico di Aviano CRO-IRCCS, Aviano, Italy.
Andrea MalgeriDepartment of Medical Oncology, Fondazione Policlinico Campus Bio-Medico, Roma, Italy.
Pasquale RescignoTranslational & Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
Alessio SignoriDepartment of Health Sciences, Section of Biostatistics, University of Genova, Genova, Italy.
Alessandro AcunzoDepartment of Medicine & Surgery, University of Parma, Parma, Italy.
Enrico Maria SiliniDepartment of Medicine & Surgery, University of Parma, Parma, Italy.
Giulia MazzaschiDepartment of Medicine & Surgery, University of Parma, Parma, Italy.
Sebastiano ButiDepartment of Medicine & Surgery, University of Parma, Parma, Italy.ORCID 0000-0003-0876-0226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellErythrocytesKidney NeoplasmsNivolumabAdultAgedAged, 80 and overErythrocyte IndicesFemaleHumansMaleMiddle AgedNeoplasm MetastasisPrognosisRetrospective StudiesNivolumabmetastatic renal cell carcinomaoverall survivalprognosisprogression-free survivalred blood cell-based score

Identifiers

PMID39105621
PMCPMC11486140

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.